The cannabis industry has managed to remain extremely successful over the course of the past year or so, but new updates to legislation and the changing public perception of cannabis have all meant that investors are looking for the next thing in the marijuana space. Innovation seems to be at the core of the market, and as more companies continue to go public, it seems as though this is becoming the norm throughout the business. Here are a few companies that are working to change the game when it comes to cannabis.
The first company on the list and one that shouldn’t come as a surprise is the company GW Pharmaceuticals (NASDAQ:GWPH). The company has been working in the biotech side of the cannabis space for some time now and has helped to create some of the most groundbreaking drugs with the use of cannabis components that we have today. According to one report “ Initial products such as Epidiolex and Sativex are used to treat epilepsy and spasticity caused by multiple sclerosis. And the growing acceptance of medical — and even recreational — marijuana likely will help GWPH longer term.” This said, GW remains one of the key stocks to watch for the long term of the cannabis market as the drug becomes more widely accepted throughout the world.
The next stock on the list and one of the largest in the industry is the company Tilray (NASDAQ :TLRY). The company recently went public, and soon after its IPO, the price shot up as many stocks do similarly in the industry. The company has been apart of the growing top tier of the cannabis space for some time now, and has received high valuations due to its relation to other companies that have been receiving large investments as of recent. In regard to what Tilray does, they are one of the larger producers of cannabis throughout the industry, and have been working to build up a massive supply of the substance so that they can continue to compete amongst the top tier of suppliers once recreational marijuana hits the market in Canada on October 17th. Tilray remains one of the most important stocks to watch throughout the stronghold companies in the marijuana space.
The last stock on the list is the company GT Biopharma (OTC:GTBP). The company has been working amongst the highly lucrative biotech space within the cannabis industry, and has remained one of the interesting stocks to watch over the past few months. The company recently announced the appointment of David Cardino, as the VP of Finance. The company stated directly that “Dave brings extensive pharmaceutical and biotech experience to GT and is a valuable and timely addition to our team. Given our strong portfolio and compelling science we continue to attract talented colleagues such as Dave. I am looking forward to working with Dave and continuing our culture of fiscal discipline and budget oversight.” As the competition continues to increase amongst the cannabis industry, having highly experienced officials in a business can help to make or break whether or not a company will survive.
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC, Midam Ventures LLC and GT Biopharma, Midam has been paid $200,000 from the company and ZERO shares of GT Biopharma Inc. for a duration beginning July 16, 2018 and ending August 16, 2018. Midam Ventures has been paid an additional $200k by GT Biopharma and has extended its marketing period through Sept 16, 2018. We may buy or sell additional shares of (GTBP) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. As of September 5, 2018 a member of MAPH Enterprises LLC holds 39 Put options of Tilray (TLRY) Expiring October 19.These may be sold at any point. This disclaimer will be updated at such time.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
